Suppr超能文献

基于浸润性导管癌组织学异质性的评分系统对淋巴结阴性乳腺癌患者的预后意义。

Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients.

作者信息

Kurosumi Masafumi, Tabei Toshio, Inoue Kenichi, Takei Hiroyuki, Ninomiya Jun, Naganuma Rin, Suemasu Kimito, Higashi Yasuhiro, Tsuchiya Eiju

机构信息

Department of Pathology, Saitama Cancer Center, 818 Komuro, Ina-machi, Kitaadachi-gun, Saitama 362-0806, Japan.

出版信息

Oncol Rep. 2003 Jul-Aug;10(4):833-7.

Abstract

This study aimed to determine the prognostic significance of histological scoring system based on heterogeneity of invasive ductal carcinoma, for node-negative breast cancer patients. We studied 108 patients of node-negative invasive ductal carcinoma with invasive tumor >5 mm. Histological score of each patient was evaluated based on histological subtype of invasive ductal carcinoma and pattern of its heterogeneity. Score of each subtype was defined as follows; papillotubular carcinoma: score 1, solid-tubular carcinoma: score 2 and scirrhous carcinoma: score 3. The existence of histological heterogeneity was examined, and corresponding score was doubled in a pure case and scores of two dominant subtypes were summed in a composite case. Overall survival curves defined by sores were drawn by Kaplan-Meier method and the difference in survival rate was evaluated by log-rank test. The most significant difference of overall survival was recognized between low score group (scores 2, 3 and 4) and high score group (scores 5 and 6) (p<0.001). In addition, multivariate analysis confirmed that only histological score was an independent prognostic factor. These results suggested that assessment of histological heterogeneity of invasive ductal carcinoma could serve as independent potent prognostic factor for node-negative invasive ductal carcinoma of the breast, and this method might be useful to decide indication of postoperative adjuvant chemotherapy.

摘要

本研究旨在确定基于浸润性导管癌异质性的组织学评分系统对腋窝淋巴结阴性乳腺癌患者的预后意义。我们研究了108例肿瘤浸润>5mm的腋窝淋巴结阴性浸润性导管癌患者。根据浸润性导管癌的组织学亚型及其异质性模式评估每位患者的组织学评分。各亚型的评分定义如下:乳头管状癌:评分为1分;实体管状癌:评分为2分;硬癌:评分为3分。检查组织学异质性的存在情况,在单纯病例中相应评分加倍,在复合病例中将两种主要亚型的评分相加。通过Kaplan-Meier法绘制由评分定义的总生存曲线,并通过对数秩检验评估生存率的差异。在低分组合(2分、3分和4分)与高分组合(5分和6分)之间观察到总生存的最显著差异(p<0.001)。此外,多因素分析证实只有组织学评分是独立的预后因素。这些结果表明,评估浸润性导管癌的组织学异质性可作为腋窝淋巴结阴性浸润性导管癌独立且有效的预后因素,该方法可能有助于确定术后辅助化疗的适应证。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验